AngioLab (XKRX:251280) ROE % Adjusted to Book Value : -4.69% (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is AngioLab ROE % Adjusted to Book Value?

AngioLab's ROE % for the quarter that ended in Dec. 2023 was -74.51%. AngioLab's PB Ratio for the quarter that ended in Dec. 2023 was 15.88. AngioLab's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -4.69%.

AngioLab ROE % Adjusted to Book Value Historical Data

The historical data trend for AngioLab's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioLab ROE % Adjusted to Book Value Chart

AngioLab Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-10.35

-5.79

-4.69

AngioLab Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial			-	-	-10.35	-5.79	-4.69

Competitive Comparison of AngioLab's ROE % Adjusted to Book Value

For the Biotechnology subindustry, AngioLab's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AngioLab's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AngioLab's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where AngioLab's ROE % Adjusted to Book Value falls into.

AngioLab ROE % Adjusted to Book Value Calculation

AngioLab's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-74.51%	/	15.88
	=	-4.69%

AngioLab's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-74.51%	/	15.88
	=	-4.69%

AngioLab ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of AngioLab's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

AngioLab (XKRX:251280) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN

Website

http://www.angiolab.co.kr

AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

AngioLab (XKRX:251280) Headlines

No Headlines